As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

PBMs demand discounts and rebates from drugmakers, which leads the manufacturers to charge higher list ... Cuban Cost Plus Drugs in 2022 to upend the byzantine $500 billion U.S. drug market ...

While the New Year's tradition of drug price hikes has held firm for years, pharma companies have decidedly tamped down on ...

More than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning ...

The reality is that there's a long list of middlemen that obfuscate ... "It's very, very simple. If all drug manufacturers would sell to Cost Plus Drugs at a competitive price, then all drugs ...

The U.S. continues to charge significantly higher prices for prescription drugs compared to similarly wealthy countries.

Before the law, there was no cap on what Medicare enrollees might have to spend on medications covered by their Part D drug ...

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...

And how much does it really cost to bring a drug to market? Increasingly, though, these debates are happening when everyone knows that the list price is not the ‘real’ price to be paid ...

The year 2024 was arguably the last time in the current Marcos administration that seeking constitutional revision was ...

Out-of-pocket costs for prescription medications will be capped at $2,000 a year for seniors on Medicare Part D. Part D is a voluntary program that pays for prescription drug medication that covers ...